BeiGene
BGNE
#968
Rank
HK$157.47 B
Marketcap
HK$1,439
Share price
0.49%
Change (1 day)
22.76%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: HK$3,141 HKD on 2021-09-17

Lowest end of day price: HK$186.85 HKD on 2016-02-12

Stock price history of BeiGene from 2016 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
HK$7.76-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.84 0.66%๐Ÿ‡บ๐Ÿ‡ธ USA